Previous studies have shown that HMGB1 expression in tumour tissue is significantly higher than that in their normal counterparts and that HMGB1 levels correlate positively with tumour size, stage and prognosis of cancers, such as breast carcinoma 36, hepatocellular carcinoma 37, and lung cancer 17. This evidence concerns the gene HMGB1 and hepatocellular carcinoma.